Episode Details

The US maker of Zepbound just signed a $2.75 billion deal with Hong Kong-based Insilico Medicine for an AI-developed drug – while eurozone consumers and businesses say they expect prices to rise… and that suggests they will.

Today’s stories:

• Eli Lilly’s Got A Sparkling New AI Biopharma Deal
• Inflation Fears Are Brewing Across Europe

Try Finimize Pro